NCT06629155View on ClinicalTrials.gov

Studying Eye Movement Deficits and Cognitive Impairment in Patients with Multiple Sclerosis Using Infrared Eye Tracking and Cognitive Tests

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2027

Conditions
Multiple SclerosisInternuclear Ophthalmoplegia
Interventions
DIAGNOSTIC_TEST

Infrared oculography

Eye movements will be captured through infrared oculography and processed via in-house algorithms.

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER

NCT06629155 - Studying Eye Movement Deficits and Cognitive Impairment in Patients with Multiple Sclerosis Using Infrared Eye Tracking and Cognitive Tests | Biotech Hunter | Biotech Hunter